1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Breast cancer survival and incidence of second primary cancers after 30 years in a randomized study of two versus five years of adjuvant tamoxifen therapy
(
- Contribution to journal › Article
- 2019
-
Mark
Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe)
(
- Contribution to journal › Article
- 2018
-
Mark
Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Second-look resection for primary stage T1 bladder cancer : a population-based study
(
- Contribution to journal › Article
-
Mark
Long-term effects on the incidence of second primary cancers in a randomized trial of two and five years of adjuvant tamoxifen
(
- Contribution to journal › Article
- 2016
-
Mark
Swedish National Registry of Urinary Bladder Cancer: No difference in relative survival over time despite more aggressive treatment.
(
- Contribution to journal › Article
- 2015
-
Mark
Use of bacillus Calmette-Guérin in stage T1 bladder cancer: Long-term observation of a population-based cohort.
(
- Contribution to journal › Article
- 2013
-
Mark
Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up
(
- Contribution to journal › Article
- 2010
-
Mark
Urinary diversion after cystectomy for bladder cancer: A population-based study in Sweden
(
- Contribution to journal › Article